Minimal volume reprogramming of mononuclear cells
US12264322B2 · kind B2 · utility
0Cited by
6References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2021 |
| Grant date | Apr 1, 2025 |
| Priority date | — |
| Expiry date | Feb 3, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells. In particular aspects, the invention provides methods and compositions for reprogramming minimal volumes of umbilical cord blood obtained from cord blood segments from cryopreserved cord blood segments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.